IN3

1-(N-BENZYLOXYCARBONYL-L-LEUCINYL)-5-(3-BENZYLOXY BENZOYL)CARBOHYDRAZIDE

Created:	1999-07-08
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where IN3 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	73
Chiral Atom Count	1
Bond Count	75
Aromatic Bond Count	18

2D diagram of IN3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-(N-BENZYLOXYCARBONYL-L-LEUCINYL)-5-(3-BENZYLOXY BENZOYL)CARBOHYDRAZIDE
Systematic Name (OpenEye OEToolkits)	phenylmethyl N-[(2S)-4-methyl-1-oxo-1-[2-[[(3-phenylmethoxyphenyl)carbonylamino]carbamoyl]hydrazinyl]pentan-2-yl]carbamate
Formula	C₂₉ H₃₃ N₅ O₆
Molecular Weight	547.602
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(OCc1ccccc1)NC(C(=O)NNC(=O)NNC(=O)c3cc(OCc2ccccc2)ccc3)CC(C)C
SMILES	CACTVS	3.341	CC(C)C[CH](NC(=O)OCc1ccccc1)C(=O)NNC(=O)NNC(=O)c2cccc(OCc3ccccc3)c2
SMILES	OpenEye OEToolkits	1.5.0	CC(C)CC(C(=O)NNC(=O)NNC(=O)c1cccc(c1)OCc2ccccc2)NC(=O)OCc3ccccc3
Canonical SMILES	CACTVS	3.341	CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NNC(=O)NNC(=O)c2cccc(OCc3ccccc3)c2
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC(C)C[C@@H](C(=O)NNC(=O)NNC(=O)c1cccc(c1)OCc2ccccc2)NC(=O)OCc3ccccc3
InChI	InChI	1.03	InChI=1S/C29H33N5O6/c1-20(2)16-25(30-29(38)40-19-22-12-7-4-8-13-22)27(36)32-34-28(37)33-31-26(35)23-14-9-15-24(17-23)39-18-21-10-5-3-6-11-21/h3-15,17,20,25H,16,18-19H2,1-2H3,(H,30,38)(H,31,35)(H,32,36)(H2,33,34,37)/t25-/m0/s1
InChIKey	InChI	1.03	CEXWCIXCWCFUSI-VWLOTQADSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL340191
PubChem	5288632
ChEMBL	CHEMBL340191

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.